product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
1-Naphthyl PP1
catalog :
3063/10
quantity :
10 mg (also 50 mg)
price :
360 USD
more info or order :
citations: 6
Reference |
---|
O Neill A, Kindberg A, Niethamer T, Larson A, Ho H, Greenberg M, et al. Unidirectional Eph/ephrin signaling creates a cortical actomyosin differential to drive cell segregation. J Cell Biol. 2016;215:217-229 pubmed
|
product information
brand :
Tocris, a Bio-Techne brand
catalog number base :
3063
SKU :
3063/10
product name :
1-Naphthyl PP1
description :
Src family kinase inhibitor; also inhibits c-Abl
target :
Src Family Kinase Inhibitors
unit size :
10 mg (also 50 mg)
category :
Small Molecules
purity :
99%
storage :
Store at +4°C
observed molecular weight :
317.39
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
1-Naphthyl PP1 is a selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl. (IC50 values are 1.0, 0.6, 0.6, 18 and 22 u M for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively). Preferentially inhibits mutant over wild-type kinases (IC50 values are 1.5 vs 1000 nM for I338G v-src and v-src respectively).
product keywords :
Src family kinase inhibits inhibitors c-Abl v-Src c-Fyn 1-NaphthylPP1 1NAPP1 1-NA-PP 1 Src Kinases Abl Kinase 3063,
extended description :
Src family kinase inhibitor; also inhibits c-Abl
chemical name text :
1-(1,1-Dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
formula :
C19H19N5
formula text :
C19H19N5
cas num :
221243-82-9
USD :
356
USD 2025 :
360 USD
product details :
Src family kinase inhibitor; also inhibits c-Abl
alt names :
1-NA-PP 1
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
related products
browse more products
questions and comments